PAM used upstream of a membrane system requires an explicit compatibility review. Improving visible clarification does not prove that the treated water is safe for a particular membrane or treatment train. Do not purchase or dose polymer directly into a membrane feed on the assumption that all flocculants are harmless.
Identify the membrane and pretreatment arrangement
State the membrane type, supplier requirements and the location of coagulation, flocculation and solids separation. Distinguish upstream clarification from direct membrane-feed dosing. Describe any intervening filtration and other chemicals that may interact with the polymer. Request advice from the membrane or system supplier before changing the pretreatment product. A generic statement that PAM works in water treatment cannot establish compatibility with a particular membrane material or operating mode.
Control residuals and solids carryover
Assess the clarified-water quality and the risk of polymer or floc carryover under normal and upset conditions. Overdosing or unstable upstream separation may create a different membrane-feed condition from the successful jar test. Define monitoring and operating limits with the responsible system team. Do not assume that greater clarity necessarily means lower fouling risk. The overdose and floc-failure guide helps identify upstream conditions that need investigation before qualification.
Use compatibility evidence, not a universal claim
Membrane response depends on polymer characteristics, water constituents and operating conditions. Primary research on organic-polymer fouling of microfiltration membranes illustrates why a flocculation benefit does not settle the compatibility question. That study is context-specific and is not an approval of a Xinqi product. Evaluate the proposed treatment train using supplier guidance and an appropriate monitored trial; do not transfer one study’s outcome to a different membrane.
Define who releases a product change
Keep pretreatment operations, the membrane team and purchasing aligned on the candidate identity, dose range and acceptable feed quality. Include a monitored changeover and response procedure if performance deteriorates. The replacement-grade guide can organize the commercial and operating evidence, but it does not substitute for membrane compatibility approval. Quote only the product and duty that have been reviewed; any unresolved downstream concern should remain an explicit condition.
Purchase review worksheet
Complete the evidence column with measured values, observations or an agreed document reference. An unanswered item is a reason to clarify the sample or quotation, not to assume that two products are equivalent. Keep the same worksheet with the trial record so the purchasing and operating teams approve the same conditions.
| Review item | Evidence to obtain | Decision before ordering |
|---|---|---|
| System | Membrane type and supplier requirements | Compatibility review precedes product approval |
| Carryover | Residual or floc risk and upstream separation quality | Feed conditions remain within agreed limits |
| Change control | Monitored trial and responsible approver | No direct dosing or substitution by assumption |
Request a focused PAM flocculant quotation
Send the feed source, solids concentration, pH or conductivity, operating temperature and separator type alongside the monthly quantity, package preference and destination. Include the specific observations in the worksheet above. If a current grade is being replaced, provide its available technical data and the active dose rather than only the trade name. Commercial availability, sample quantities and delivered terms should be confirmed for the selected product, not inferred from an illustrative application.
Arrange the comparison through the PAM trial planner and review quality documents and supply requirements before committing to a shipment. Gongyi Xinqi Polymer Co., Ltd. can review the application information and discuss a suitable sample range. Application suitability remains conditional on representative testing; a polymer recommendation is not a guarantee of plant performance or regulatory compliance.